Aimei Health Technology Co., Ltd (Ticker: AFJKR) is at the forefront of healthcare innovation, utilizing artificial intelligence to improve patient care with cutting-edge diagnostic and treatment solutions. The company is strategically aligned to capitalize on the surging demand for digital health services, leveraging operational efficiencies to drive growth in a dynamic market landscape. Aimei’s dedication to developing next-generation products that enhance patient outcomes makes it an attractive investment opportunity, particularly for institutional investors seeking to engage with the transformative advancements in the health technology sector.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.08% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -43.40% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.44M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding